logo
Select company
Select metric
-1920.2%EBIT Margin
VS
Market
4
Sector
15
Industry
28
History
20
$ 2.21Close
$ 1.1 - $ 5.94 52-Week Range
Ticker Information

Ticker

TCRX

Company Name

TSCAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TSCAN THERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TCRX - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -133.66M-1920.2%$ 6.96M
3/31/2025$ -128.11M-2897.78%$ 4.42M
12/31/2024$ -123.85M-4397.94%$ 2.82M
9/30/2024$ -107.58M-1149.13%$ 9.36M
6/30/2024$ -100.67M-825.15%$ 12.2M
3/31/2024$ -93.03M-628.11%$ 14.81M
12/31/2023$ -85.46M-406%$ 21.05M
9/30/2023$ -84.45M-498.71%$ 16.93M
6/30/2023$ -78.47M-478.24%$ 16.41M
3/31/2023$ -70.5M-407.09%$ 17.32M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TSCAN THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at -2408.02%.
  • Over the past 5 years, TSCAN THERAPEUTICS INC's average EBIT % has been -1152.89%.
  • The median EBIT % for TSCAN THERAPEUTICS INC during this period was -504.71%
  • TSCAN THERAPEUTICS INC reached its highest EBIT % over the past 5 years at -406%.
  • The lowest EBIT % recorded by TSCAN THERAPEUTICS INC in the same timeframe -4397.94%

TSCAN THERAPEUTICS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
CRVO : CERVOMED INC -290.75%FATE : FATE THERAPEUTICS INC -2025.05%OVID : OVID THERAPEUTICS INC -574.02%ARMP : ARMATA PHARMACEUTICALS INC -287.4%CBUS : CIBUS INC -4975.71%CUE : CUE BIOPHARMA INC -463.15%VERU : VERU INC -482.04%SRZN : SURROZEN INC -325.06%PSTV : PLUS THERAPEUTICS INC -287.76%KRRO : KORRO BIO INC -1452.95%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for TSCAN THERAPEUTICS INC is calculated as follows: EBIT [ $ -26.13M ] / Revenues [ $ 1.08M ]
(=) EBIT % [ -2408.02% ]

TCRX - EBIT Margin, Last 5 years

-4397.94%

Minimum

Dec 31, 2024

-406%

Maximum

Dec 31, 2023

-1152.89%

Average

-504.71%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%